Collection of various sample types from patients with rare/emerging or exotic viruses and Rickettsia for molecular and serological diagnostic test development and validation purposes.
- Conditions
- Rickettsial infectionexotic and/or emerging arboviral and other infectionrare and exotic diseases from which some are transmitted by mosquito and other insects10047438
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 100
*adult and fully capable person
*written informed consent provided
*strong clinical suspicion by infectious disease clinical specialists of
infection with rare/emerging or exotic viruses or Rickettsiae spp based on
signs and symptoms in combination with relevant travel history and/or
activities presenting at any departments or out-patient clinic of the EMC or
confirmed positive external patients/participants (Figure 1, Appendix 1 and 2).
Patients will be approached and included by infectious disease clinical
specialists, by their treating physician or through municipal public health
services or recruited via advertisement.
*written Informed consent NOT provided
* <18 year old
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method